Boehringer Ingelheim Archives -

How effective data management can support NHS Trusts to hit their targets

Roche, Boehringer tap biosensor firms for patient studies

Phil Taylor Boehringer Ingelheim, clinical trials, digital, digital health, neurology, patient monitoring, respiratory, Roche, Strados Labs, Sysnav, wearables 0 Comment

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable

Roche, Boehringer tap biosensor firms for patient studies

https://pharmaphorum.com/news/roche-boehringer-tap-biosensor-firms-for-patient-studies/

News/ News/ Sales and Marketing

Boehringer, Takeda make it into global top 15 employer list

Phil Taylor Boehringer Ingelheim, employ, human resources, Takeda 0 Comment

Boehringer Ingelheim and Takeda are the only two pharmaceutical groups to be named among the 15 Global Top

Boehringer, Takeda make it into global top 15 employer list

https://pharmaphorum.com/news/boehringer-takeda-make-it-into-global-top-15-employer-list/

Digital/ News/ News/ News/ R&D

BI, Click Therapeutics expand collaboration to PDT for schizophrenia

Nicole Raleigh Boehringer Ingelheim, Click Therapeutics, collaboration, digital therapeutics, mental health, PDT, schizophrenia 0 Comment

Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their collaboration to develop and commercialise a

BI, Click Therapeutics expand collaboration to PDT for schizophrenia

https://pharmaphorum.com/news/bi-click-therapeutics-expand-collaboration-to-pdt-for-schizophrenia/

Market Access/ News/ News/ News/ Patients

NICE backs use of Boehringer’s Ofev in IPF from diagnosis

Phil Taylor Boehringer Ingelheim, Esbriet, HEOR, idiopathic pulmonary fibrosis, NHS, NICE, Ofev, Roche 0 Comment

Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim’s

NICE backs use of Boehringer’s Ofev in IPF from diagnosis

https://pharmaphorum.com/news/nice-backs-use-of-boehringers-ofev-in-ipf-from-diagnosis/

Appointments/ News/ Sales and Marketing

Changing Faces: biopharma hires from November 2022

Jonah Comstock Acelyrin, ADC Therapeutics, Almirall, Amarin Pharmaceuticals, Amy Levin, Angelini Pharma, AstraZeneca, Atriva Therapeutics, Barbara Sanders, biopharma hires, Boehringer Ingelheim, C-Suite, Carlos Gallardo, Christian Pangratz, Elena Ritsou, Imophoron, Incyte Biosciences, Jacopo Andreose, James McCarthy, Jérôme Marzinski, Kristen Harrington-Smith, Luke Devey, Lykke Hinsch Gylvin, Mainz Biomed, Mardi C. Dier, Mercedes Diaz, Mina Kim, Nivedita Valentine, Novacyt, Oxsonics Therapeutics, Peter Graham, Peter Williams, pharma hires, Pharmanovia, Quell Therapeutics, Richard Bungay, Richard Pallin, Sander van Deventer, Scott Curley, Sheena Powell, SpectrumX, Stefan Woxström, VectorY, Virax Biolabs 0 Comment

The month of November saw a number of notable hires and personnel moves in biotech and pharma. Read

Changing Faces: biopharma hires from November 2022

https://pharmaphorum.com/news/changing-faces-biopharma-hires-from-november-2022/

News/ News/ Sales and Marketing

US court throws out lawsuits alleging Zantac caused cancer

Phil Taylor Boehringer Ingelheim, GlaxoSmithKline, Haleon, Johnson & Johnson, litigation, Pfizer, safety, Zantac 0 Comment

Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought

US court throws out lawsuits alleging Zantac caused cancer

https://pharmaphorum.com/news/us-court-throws-out-lawsuits-alleging-zantac-caused-cancer/

News/ News/ R&D

Boehringer recruits former Novartis’ neurosciences head as its CMO

Phil Taylor appointment, Boehringer Ingelheim, R&D, senior management 0 Comment

Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief medical officer, succeeding

Boehringer recruits former Novartis’ neurosciences head as its CMO

https://pharmaphorum.com/news/boehringer-recruits-former-novartis-neurosciences-head-as-its-cmo/

connecting to the global patient community

Digital/ News/ News/ News/ R&D

Boehringer taps Medidata e-clinical tech for another five years

Phil Taylor Boehringer Ingelheim, clinical trials, decentralised clinical trials, electronic data capture, Medidata 0 Comment

Boehringer Ingelheim was an early adopter of Medidata’s electronic data collection (EDC) platform for clinical trials, and has

Boehringer taps Medidata e-clinical tech for another five years

https://pharmaphorum.com/news/boehringer-taps-medidata-e-clinical-tech-for-another-five-years/

Boehringer Ingelheim, Biberach, Germany, February 2007

News/ News/ R&D

Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3

Phil Taylor Boehringer Ingelheim, interstitial lung diseases, Ofev, respiratory 0 Comment

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550

Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3

https://pharmaphorum.com/news/seeking-ofev-successor-boehringer-takes-pde4b-drug-into-phase-3/

Trending

Boehringer Ingelheim

Login